Clinical trialNCT05032352TerminatedObservational

Predictive Assay for Decision Making in Adjuvant Therapy

SponsorInsight Molecular DiagnosticsEnrollment55Carcinoma, Non-Small-Cell Lung

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Prospective Registrational Trial to Define Real World Outcomes of Patients with Completely Resected Stage I or IIA (tumor \< or = 5cm, node negative) Non-squamous Non-Small Lung Cancer (NSCLC) Identified as High, Intermediate, or Low Risk by a 14-Gene Prognostic Assay DetermaRx being Considered for Adjuvant Platinum-based chemotherapy or other adjuvant therapy versus Observation

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Corey Langer, MD
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

City of Hope National Medical Center
Duarte, California, United States
George Washington Medical Faculty Associates
Washington D.C., District of Columbia, United States
Medstar Washington Hospital Center
Washington D.C., District of Columbia, United States
Jupiter Medical Center
Jupiter, Florida, United States
Piedmont Cancer Center
Atlanta, Georgia, United States
Northshore University Healthsystem
Evanston, Illinois, United States
the University of Kansas Hospital
Kansas City, Kansas, United States
Our Lady of the Lake Regional Medical Center
Baton Rouge, Louisiana, United States
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania, United States
Methodist Healthcare
San Antonio, Texas, United States
Texas Oncology-San Antonio Medical Center
San Antonio, Texas, United States
Texas Oncology-Wichita Falls Cancer Center
Wichita Falls, Texas, United States
Virginia Cancer Specialists
Fairfax, Virginia, United States
Mary Washington Hospital
Fredericksburg, Virginia, United States
Providence Regional Medical Center Everett
Everett, Washington, United States
Peace Health
Vancouver, Washington, United States
West Virginia University Medicine
Morgantown, West Virginia, United States
Medical College of Wisconsin
Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Adjuvant

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 28 Jan 2022
Primary completion: 28 Oct 2022
Completion: 28 Oct 2022
Last update posted: 14 Nov 2022
Registered enrollment: 55
Registry id: NCT05032352

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.